Localized Oesogastric Adenocarcimona research hub

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

This study is testing two new immunotherapy drugs, nivolumab and ipilimumab, before surgery for a specific type of stomach or gullet cancer. We want to see if this treatment can reduce the cancer significantly before the operation.